Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Thompson

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Cancer Cell|June 15, 2010
Grappling with the androgen receptor: a new approach for treating advanced prostate cancerTimothy C Thompson
Cancer Cell|November 13, 2007
Suppression of tumor suppressors in prostate cancer: the emergence of a novel oncogenic pathwayTimothy C Thompson
Cancer Cell|June 14, 2011
Turning reciprocal feedback regulation into combination therapyTimothy C Thompson
Yonsei Medical Journal|May 26, 2010
Glioma pathogenesis-related protein 1: tumor-suppressor activities and therapeutic potentialTimothy C Thompson
Cancer Cell|July 13, 2013
GEMMs shine a light on resistance to androgen deprivation therapy for prostate cancerTheodoros Karantanos, Timothy C Thompson
Cancer Letters|April 9, 2008
Perifosine induces differentiation and cell death in prostate cancer cellsDaniel Floryk, Timothy C Thompson
International Journal of Cancer|August 21, 2008
Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cellsDaniel Floryk, Timothy C Thompson
Molecular & Cellular Oncology|August 19, 2017
Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancerTimothy C Thompson, Likun Li
Cancer Management and Research|December 29, 2010
Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefitPaul G Corn, Timothy C Thompson
Nature Reviews. Urology|February 27, 2021
Considering the potential for gene-based therapy in prostate cancerJustin R Gregg, Timothy C Thompson
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Cancer Cell|June 15, 2010
Grappling with the androgen receptor: a new approach for treating advanced prostate cancerTimothy C Thompson
Cancer Cell|November 13, 2007
Suppression of tumor suppressors in prostate cancer: the emergence of a novel oncogenic pathwayTimothy C Thompson
Cancer Cell|June 14, 2011
Turning reciprocal feedback regulation into combination therapyTimothy C Thompson
Yonsei Medical Journal|May 26, 2010
Glioma pathogenesis-related protein 1: tumor-suppressor activities and therapeutic potentialTimothy C Thompson
Cancer Cell|July 13, 2013
GEMMs shine a light on resistance to androgen deprivation therapy for prostate cancerTheodoros Karantanos, Timothy C Thompson
Cancer Letters|April 9, 2008
Perifosine induces differentiation and cell death in prostate cancer cellsDaniel Floryk, Timothy C Thompson
International Journal of Cancer|August 21, 2008
Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cellsDaniel Floryk, Timothy C Thompson
Molecular & Cellular Oncology|August 19, 2017
Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancerTimothy C Thompson, Likun Li
Cancer Management and Research|December 29, 2010
Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefitPaul G Corn, Timothy C Thompson
Nature Reviews. Urology|February 27, 2021
Considering the potential for gene-based therapy in prostate cancerJustin R Gregg, Timothy C Thompson
Pageof 12